0.829
IF
20
MNiSW
166.26
ICV
RESEARCH PAPER
 
CC BY-NC-ND 3.0
 
 

Intensification of menopausal symptoms among female inhabitants of East European countries

Iwona Bojar 1  ,  
Jozef Novotny 3,  
Alfred Owoc 6,  
 
1
Department for Woman Health, Institute of Rural Health, Lublin, Poland
2
Department Public Health Management, Lviv National Medical University named after Danylo Halytskyi, Ukraine
3
College of Polytechnics, Department of Health Care Studies, JIHLAVA, Czech Republic
4
University of Ss. Cyril and Methodius, Trnava, Slovak Republic
5
State Medical University, Grodno, Belorus
6
Centre for Public Health and Health Promotion, Institute of Rural Health, Lublin, Poland, Poland
7
Institute of Statistics and Demography, Warsaw School of Economics, Warsaw, Poland
Ann Agric Environ Med 2016;23(3):517–524
KEYWORDS:
ABSTRACT:
The objective of the study was analysis of the occurrence and intensity of menopausal symptoms in postmenopausal women from Poland, Belarus, Ukraine, Czech Republic, Slovakia and Poland. The study was conducted during the period 2014–2015 among postmenopausal women living in the areas of Poland, Belarus, Ukraine, Czech Republic and Slovakia. The degree of menopausal complaints was assessed using the Kupperman Menopausal Index and Greene Climacteric Scale. The respondents were additionally asked about age, educational level, place of residence, marital status and age at last menstrual period. Into the study were enrolled women aged 50–65, minimum 2 years after the last menstrual period, who had a generally good state of health and did not use hormone replacement therapy. The results were subjected to statistical analysis. The intensity of all menopausal symptoms measured by the Kupperman Menopausal Index and Greene Climacteric Scale was similar in Poland, Czech Republic and Slovakia. In these countries, severe, moderate and mild menopausal symptoms measured by Kupperman Menopausal Index occurred with a similar frequency. Similar results were also obtained in the subscales of psychological, somatic and vasomotor symptoms according to the Greene Climacteric Scale. Nearly a half of the women from Belarus did not report symptoms measured by Kupperman Menopausal Index. They obtained significantly lower menopausal complaints in the subscales of psychological and somatic symptoms according to the Greene Climacteric Scale, compared to the inhabitants of the remaining countries. The majority of women from the Ukraine had mild menopausal symptoms as measured by the Kupperman Menopausal Index. They had significantly more severe complaints in the subscales of psychological, somatic and vasomotor symptoms according to the Greene Climacteric Scale, compared to the inhabitants of the remaining countries in the study. The intensity of menopausal symptoms in women from Ukraine and Belarus was related with educational level, place of residence, and marital status, whereas in women from Poland, Czech Republic and Slovakia, only with marital status.
CORRESPONDING AUTHOR:
Iwona Bojar   
Department for Woman Health, Institute of Rural Health, Lublin, Poland
 
REFERENCES:
1. Grycewicz J, Cypryk K. Wpływ hormonów płciowych na występowanie zaburzeń metabolicznych u kobiet w okresie menopauzy. Prz Menopauz. 2008; 1: 29–37.
2. Skałba P. Endokrynologia ginekologiczna. Wydawnictwo Lekarskie PZWL. Wyd III 2008 Rozdz 11: 307–333.
3. Bielawska-Batorowicz E. Koncepcje menopauzy. Część I– ujęcie demograficzne i kulturowe. Prz Menopauz. 2005; 2: 10–18.
4. Szkup-Jabłońska M, Tutaj E, Jurczak A, Wieder-Huszla S, Brodowska A, Grochans E. Wpływ warunków socjodemograficznych na jakość życia kobiet w okresie pomenopauzalnym. Perinatologia, Neonatologia i Ginekologia. 2012; 1(5): 34–38.
5. Jędrzejuk D. Wiek menopauzy uwarunkowania demograficzne. W: Endokrynologia kliniczna. Milewicz A (red.). Polskie Towarzystwo Endokrynologiczne, Wrocław 2012.
6. World Health Organization. The European health cohort 2012. Charting the way to well-being.
7. Skałba P. Objawy wypadowe. W: Endokrynologia kliniczna. Milewicz A (red.). Polskie Towarzystwo Endokrynologiczne, Wrocław 2012.
8. Greene JG. A factor analytic study of climacteric symptoms. J Psychosom Res. 1976; 20: 425–430.
9. Kupperman HS, Blatt MHG, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal idices. J Clin Endocrinol. 1953; 13: 688–703.
10. Avis NE, Colvin A, Bromberger JT, Hess R, Matthews KA, Ory M, Schocken M. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of women’s health across the nation. Menopause. 2009; 16: 860–869.
11. Wieder-Huszla S, Grześkowiak H, Jurczak A, Pilch D, Stanisławska M, Szkup-Jabłońska M, Augustyniuk K, Grochans E. Style radzenia sobie ze stresem kobiet w okresie okołomenopauzalnym z uwzględnieniem intensywności objawów wypadowych. Problemy Pielęgniarstwa. 2014; 22(1): 82–90.
12. Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas. 2007; 57(3): 271–8.
13. Bal MD, Sahin NH. The effects of personality traits on quality of life. Menopause. 2011; 18: 1309–1316.
14. Badania nad menopauzą w latach 90. Instytut Medycyny Pracy im. prof. J. Nofera. Łódź 2001.
15. Wojnar M, Dróżdż W, Araszkiewicz A, Szymański W, Nawacka-Pawlaczyk D, Urbański R, et al. Assessment and prevalence of depression in women 45–55 years of age visiting gynecological clinics in Poland. Arch Women’s Mental Health. 2003; 6: 193–201.
16. Holte A. The changing truth about how natural menopause affects health complaints: results from the Norwegian Menopause Project. W: K Wijma, B von Schoultz (red.) Reproductive life. Advances in research in psychosomatic obstetrics and gynecology. The Parthenon Publishing Group. Carnforth 1992.
17. Koster A, Eplov LF, Garde K. Anticipations and experiences of menopause in a Danish female general population cohort born in 1936. Arch Women’s Mental Health. 2002; 5: 9–13.
18. Jokinen K, Rautava P, Makinen J, Ojanlatva A, Sundell J, Helenius H. Experience of climacetic symptoms among 42–46 and 52–56-year-old women. Maturitas. 2003; 46: 199–205.
19. Conboy L, Domar A, O’Connell E. Women at mid-life: symptoms, attitudes, and choices, an internet based survey. Maturitas. 2001; 38: 129–36.
20. Lam PM, Leung TN, Haines C, Chung TK. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40–60 years. Maturitas. 2003; 45: 99–107.
21. Pan HA, Wu MH, Hsu CC, Yao BL, Huang KE. The perception of menopause among women in Taiwan. Maturitas. 2002; 41: 269–74.
22. Xiao B, Ge QS. Role of reproductive health in the quality of life of women in the menopause. In: T Aso, T Yanaihara, S Fujimoto (ed.). The menopause at the millenium. The proceedings of the 9th International Menopause Society World Congress on the Menopause. The Parthenon Publishing Group. New York 2000.
23. Obermeyer CM, Schulein M, Hajji N, Azelmat M. Menopause in Marocco: symptomatology and medical management. Maturitas. 2002; 41: 87–95.
24. Limpaphayom KK. Healthy aging in the 21st century. W: T Aso, T Yanaihara, S Fujimoto (red.). The menopause at the millenium. The proceedings of the 9th International Menopause Society World Congress on the Menopause. The Parthenon Publishing Group. New York 2000.
25. Humeniuk E, Bojar I, Owoc A, Wojtyła A, Fronczak A. Psychosocial conditioning of depressive disorders in post-menopausal women. Ann Agric Environ Med. 2011; 18(2): 441–5.
26. Bojar I, Wojcik-Fatla A, Owoc A, Lewinski A. Polymorphisms of apolipoprotein E gene and cognitive functions of postmenopausal women, measured by battery of computer tests – Central Nervous System Vital Signs. Neuro Endocrinol Lett. 2012; 33(4): 385–92.
27. Mondul AM, Rodriguez C, Jacobs EJ, Calle EE. Age at natural menopause and cause-specific mortality. Am J Epidemiol. 2005; 162(11): 1089–97.
28. Al-Azzawi F, Palacios S. Hormonal changes during menopause. Maturitas. 2009; 63(2): 135–137.
29. Nelson HD. Menopause. Lancet. 2008; 371: 760–70.
30. North American Menopause Society. Menopause Guidebook, 6th end. http://www.menopause.org/MGI.pdf (access: 16.08.2016).
31. Ortmann O, Dören M, Windler E. Hormone therapy in perimenopause and postmenopause (HT): Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstet. 2011; 284: 343–355.
32. Freeman EW, Sammel MD, Lin H, Liu Z, Gracia CR. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol. 2011; 117(5): 1095–104.
33. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein Fn, Heiman JR, et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause. 2008; 15: 584–602.
34. Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004; (4) CD002978.
35. Eberhardt S, Kulp W, von der Schulenburg JM, Willich SN, Keil T, Greiner W. Hormones for therapy of climacteric afflictions. GMS Health Technology Assessmen. 2007; 3 Doc03.
36. Vesco KK, Haney EM, Humphrey L, Fu R, Nelson HD. Influence of menopause on mood: a systematic review of cohort studies. Climacteric: the journal of the International Menopause Society. 2007; 10: 448–465.
37. Ortmann O, Dören M, Windler E. Hormone therapy in perimenopause and postmenopause (HT): Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstet. 2011; 284: 343–356.
38. Warenik-Szymankiewicz A. [Estrogens and aging in women]. Pol Arch Med Wewn. 2001; 105 (supl.): 105–110.
39. Pertyński T, Stachowiak G. Współczesne poglądy na opiekę menopauzalną. Przew Lek. 2010; 2: 146–148.
40. Grigoriou V, Augoulea A, Armeni E, Rizos D, Alexandrou A, Dendrinos S, Panoulis K, Lambrinoudaki I. Prevalence of vasomotor, psychological, psychosomatic and sexual symptoms in perimenopausal and recently postmenopausal Greek women: association with demographic, life-style and hormonal factors. Gynecol Endocrinol. 2013; 29(2): 125–8.
41. Jian-Ping Zhang, Yao-Qin Wang, Mei-Qin Yan, Zhao-Ai Li, Xiu-Ping Du, and Xue-Qing Wu. Menopausal Symptoms and Sleep Quality During Menopausal Transition and Postmenopause. Chin Med J (Engl). 2016; 129(7): 771–777.
42. Zhang QX, Yang DZ, Wang WJ, Liang XY, Xie MQ, Wang LA, et al. The prevalence of climacteric symptoms in Guangzhou with report of 1090 women (in Chinese) Maternal &Child Health Care Chin. 2004; 19: 95–8.
43. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, Salamone L, Stellato R. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol. 2000; 152(5): 463–73.
44. Anderson D, Yoshizawa T, Gollschewski S, Atogami F, Courtney M. Menopause in Australia and Japan: effects of country of residence on menopausal status and menopausal symptoms. Climacteric. 2004; 7(2): 165–74.
45. Islam MR, Gartoulla P, Bell RJ, Fradkin P, Davis SR. Prevalence of menopausal symptoms in Asian midlife women: a systematic review. Climacteric. 2015; 18(2): 157–76.
46. Skrzypulec V, Naworska B, Drosdzol A. Analiza wpływu objawów klimakterycznych na funkcjonowanie i jakość życia kobiet w okresie około menopauzalnym. Prz Menopauzal. 2007; 2: 96–101.
47. Gharaibeh M, Al-Obeisat S, Hattab J. Severity of menopausal symptoms of Jordanian women. Climacteric. 2010; 13(4): 385–94.
48. Krajewska K. Analiza porównawcza jakości życia kobiet w okresie menopauzy w Polsce i Grecji z zastosowaniem skali MRS i Indeksu Kuppermana. Doniesienie wstępne. Zakład Pielęgniarstwa Ogólnego AMB 2007.
49. Bień A, Rzońca E, Iwanowicz-Paus G, Pańczuk-Szeptuch M. The influence ofclimacteric symptoms of women’s Lives and Activities. Int J Environ Res Public Health. 2015; 12: 3835–3846.
50. Li C, Samsioe G, Borgfeldt C, Lidfeld, J, Agardh CD. Menopause—Related symptoms: What are background factors? A prospective population—Based cohort study of Swedish women (The Women’s Health in Lund Area study). Am J Obstet Gynecol. 2003; 189: 1646–1653.
51. Joseph N, Nagaraj K, Saralaya V, Nelliyanil M, Rao PJ. Assessment of menopausal symptoms among women attending various outreach clinics in South Canara District of India. J Midlife Health. 2014; 5: 84–90.
52. Cheng MH, Wang SJ, Wang PH, Fuh JL. Attitudes toward menopause among middle-aged women: a community survey in an island of Taiwan. Maturitas. 2005; 52(3–4): 348–55.
53. Makara-Studzińska M, Kryś-Noszczyk K, Jakiel G. The influence of selected socio-demographic variables on symptoms occurring during the menopause. Prz Menopauz. 2015; 14: 20–26.
54. The Greene Menopause Index, also known as the Greene Climateric Scale, is a questionnaire a tool used by researchers to study the symptoms of menopause.
eISSN:1898-2263
ISSN:1232-1966